BK251199

by Pill Pals Customer Service | Aug 15, 2025 | News

510(k) Number: BK251199 Applicant: EUROMI S.A Device Name: NLF system® kit 2 (EUROMI)Decision Date: 8/14/2025Supporting Documents Content current as of: 08/15/2025...

Green Lumber contains hidden drug ingredient

by Pill Pals Customer Service | Aug 15, 2025 | News

[8-13-2025] FDA continues to advise consumers not to purchase or use the Green Lumber Natural Fuel For Men product. FDA laboratory analysis confirmed that additional versions of the Green Lumber product sold by Green Lumber Holdings LLC contain tadalafil. [9-19-2019]...

Certain Left Heart Vent Catheters should be removed

by Pill Pals Customer Service | Aug 15, 2025 | News

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes...

Drug Trials Snapshot: TRYPTYR

by Pill Pals Customer Service | Aug 15, 2025 | News

HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic groups. The “MORE INFO” bar...

Drug Trials Snapshots: EMRELIS

by Pill Pals Customer Service | Aug 15, 2025 | News

HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic groups. The “MORE INFO” bar...

FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis

by Pill Pals Customer Service | Aug 14, 2025 | News

For Immediate Release: August 14, 2025 Today, the U.S. Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba), a first-of-its-kind non-replicating adenoviral vector-based immunotherapy for the treatment of adult patients with recurrent...